Profile data is unavailable for this security.
About the company
West Pharmaceutical Services, Inc. is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company's products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services. The Company's segments include Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment develops commercial and operational strategies across its global network, with specific emphasis on product offerings to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as an integrated business focused on the design, manufacture and automated assembly of various devices, primarily for pharmaceutical, diagnostic and medical device customers.
- Revenue in USD (TTM)1.89bn
- Net income in USD260.60m
- Incorporated1923
- Employees8.20k
- LocationWest Pharmaceutical Services Inc530 HERMAN O WEST DREXTON 19341-1147United StatesUSA
- Phone+1 (610) 594-2900
- Fax+1 (800) 345-9800
- Websitehttps://www.westpharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Henry Schein, Inc. | 10.05bn | 712.82m | 8.77bn | 19.00k | 12.68 | 2.94 | 12.11 | 0.8725 | 4.85 | 4.86 | 68.36 | 20.88 | 1.37 | 5.16 | 8.41 | 529,179.30 | 7.24 | 6.75 | 12.10 | 12.07 | 30.69 | 29.67 | 5.28 | 4.85 | 1.04 | 26.11 | 0.2593 | 0.00 | 6.03 | -0.7549 | 67.21 | 8.50 | -1.48 | -- |
| ABIOMED, Inc. | 840.88m | 203.01m | 9.77bn | 1.54k | 49.09 | 9.18 | 43.73 | 11.62 | 4.43 | 4.43 | 18.36 | 23.67 | 0.7406 | 1.77 | 9.58 | 547,449.30 | 17.88 | 19.09 | 19.97 | 21.43 | 82.01 | 83.20 | 24.14 | 23.02 | 4.14 | -- | 0.00 | 0.00 | 9.29 | 29.56 | -21.62 | 12.29 | 53.36 | -- |
| DENTSPLY SIRONA Inc | 3.96bn | 83.80m | 10.29bn | 15.20k | 128.14 | 2.20 | 25.54 | 2.60 | 0.3667 | 0.3667 | 17.72 | 21.39 | 0.475 | 3.02 | 5.79 | 260,348.70 | 1.01 | -3.84 | 1.13 | -4.25 | 53.91 | 53.94 | 2.12 | -8.67 | 1.36 | -- | 0.2367 | -- | 1.08 | 6.63 | 125.90 | -4.03 | 3.05 | 7.50 |
| Varian Medical Systems, Inc. | 3.33bn | 235.40m | 11.27bn | 10.06k | 48.33 | 6.05 | 33.02 | 3.38 | 2.57 | 2.52 | 36.29 | 20.52 | 0.8606 | 3.49 | 3.27 | 330,759.30 | 6.10 | 8.58 | 10.60 | 15.00 | 43.27 | 42.57 | 7.09 | 10.95 | 0.9729 | -- | 0.2216 | 0.00 | 10.48 | 1.12 | -16.66 | -5.88 | -8.34 | -- |
| Insulet Corporation | 776.65m | 5.12m | 12.08bn | 1.35k | 2,288.37 | 197.27 | 328.42 | 15.56 | 0.0807 | 0.0807 | 12.39 | 0.9357 | 0.7537 | 3.26 | 9.81 | 575,292.60 | 0.4971 | -3.14 | 0.564 | -3.62 | 64.44 | 61.42 | 0.6595 | -4.19 | 3.42 | 1.46 | 0.9384 | -- | 30.93 | 26.12 | 252.37 | -- | 71.60 | -- |
| Masimo Corporation | 975.80m | 211.35m | 12.68bn | 1.60k | 63.55 | 10.12 | 53.80 | 13.00 | 3.69 | 3.69 | 17.03 | 23.16 | 0.7354 | 2.99 | 7.17 | 609,873.80 | 15.93 | 22.09 | 17.79 | 26.76 | 67.96 | 66.54 | 21.66 | 25.09 | 5.49 | -- | 0.00 | 0.00 | 9.27 | 9.84 | 0.9118 | 22.03 | -1.70 | -- |
| Hologic, Inc. | 3.32bn | 452.80m | 13.51bn | 6.48k | 31.09 | 6.48 | 15.60 | 4.06 | 1.68 | 1.68 | 12.38 | 8.08 | 0.4982 | 3.72 | 5.76 | 513,260.30 | 6.76 | 1.49 | 8.34 | 1.78 | 52.75 | 53.11 | 13.56 | 3.70 | 1.04 | 4.97 | 0.631 | 0.00 | 4.64 | 5.88 | 56.59 | -- | 7.21 | -- |
| Steris PLC | 3.03bn | 407.61m | 13.81bn | 12.00k | 34.21 | 4.05 | 32.05 | 4.56 | 4.76 | 4.76 | 35.39 | 40.17 | 0.5774 | 7.50 | 5.27 | -- | 7.77 | 4.97 | 8.57 | 5.44 | 43.55 | 41.48 | 13.45 | 9.09 | 1.91 | 19.93 | 0.2525 | 42.74 | 8.94 | 10.37 | 34.06 | 24.72 | 20.27 | 10.01 |
| West Pharmaceutical Services Inc. | 1.89bn | 260.60m | 15.16bn | 8.20k | 59.65 | 10.18 | 42.79 | 8.03 | 3.45 | 3.45 | 25.02 | 20.25 | 0.8816 | 5.29 | 5.80 | 230,231.70 | 11.70 | 9.48 | 13.77 | 11.20 | 33.15 | 32.49 | 13.27 | 10.89 | 2.11 | -- | 0.147 | 21.64 | 7.13 | 5.30 | 18.25 | 13.72 | 2.43 | 8.27 |
| Teleflex Incorporated | 2.61bn | 551.22m | 16.63bn | 14.40k | 30.66 | 5.41 | 21.67 | 6.37 | 11.68 | 11.70 | 55.39 | 66.20 | 0.4029 | 2.42 | 6.39 | 181,418.10 | 8.50 | 5.51 | 9.15 | 6.18 | 56.67 | 55.10 | 21.10 | 12.85 | 2.38 | 7.86 | 0.438 | 21.63 | 6.00 | 7.12 | 135.19 | 19.40 | 8.73 | 0.00 |
| Cooper Companies Inc | 2.67bn | 448.20m | 16.89bn | 12.00k | 35.18 | 4.18 | 23.11 | 6.32 | 9.00 | 9.12 | 53.64 | 75.83 | 0.4159 | 1.79 | 6.70 | 222,625.00 | 6.98 | 6.60 | 8.27 | 7.44 | 66.06 | 63.11 | 16.78 | 15.05 | 0.5834 | 8.06 | 0.3226 | 0.8777 | 4.76 | 9.09 | 30.01 | 11.30 | 4.18 | 0.00 |
| Align Technology, Inc. | 2.41bn | 1.89bn | 19.63bn | 14.53k | 10.45 | 6.88 | 9.96 | 8.15 | 23.85 | 23.85 | 30.24 | 36.22 | 0.7771 | 7.10 | 4.76 | 165,780.30 | 61.06 | 18.60 | 84.42 | 26.41 | 72.08 | 74.16 | 78.57 | 19.47 | 1.60 | -- | 0.00 | 0.00 | 22.39 | 25.87 | 10.63 | 24.87 | 44.10 | -- |
Data as of May 29 2020. Currency figures normalised to West Pharmaceutical Services Inc's reporting currency: US Dollar USD
45.41%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Mar 2020 | 7.54m | 10.25% |
| BlackRock Fund Advisorsas of 31 Mar 2020 | 6.20m | 8.43% |
| T. Rowe Price Associates, Inc. (Investment Management)as of 31 Mar 2020 | 5.32m | 7.23% |
| Franklin Advisers, Inc.as of 31 Mar 2020 | 4.07m | 5.53% |
| SSgA Funds Management, Inc.as of 31 Mar 2020 | 2.79m | 3.79% |
| Neuberger Berman Investment Advisers LLCas of 31 Mar 2020 | 2.15m | 2.92% |
| BAMCO, Inc.as of 31 Mar 2020 | 1.44m | 1.96% |
| WCM Investment Management LLCas of 31 Mar 2020 | 1.41m | 1.92% |
| Capital Research & Management Co. (Global Investors)as of 31 Mar 2020 | 1.30m | 1.76% |
| Artisan Partners LPas of 31 Mar 2020 | 1.20m | 1.63% |
More ▼
Data from 31 Mar 2020 - 31 Mar 2020Source: FactSet Research Systems Inc.
